Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
News » Extended use for breast cancer drug
 

Extended use for breast cancer drug

An already establish drug used to treat breast cancer has been found to be highly effective against a particularly early aggressive form of breast cancer, providing a possible cure for a small subset of women. Herceptin is a chemotherapeutic agent that targets an abnormal gene, called HER2, that can be found in a small number of breast cancer sufferers. While the drug provides positive results against a type of breast cancer with a poor prognosis, it also has serious side effects that necessitate its stringent use, such as causing heart failure.

Source: summary of medical news story as reported by USA Today.com

Related Disease Topics:

Article Source Details

About: Extended use for breast cancer drug

Date: 19 October 2005

Source: USA Today.com

Author: Rita Rubin

URL: http://www.usatoday.com/news/health/2005-10-19-breast-cancer-drug_x.htm?POE=NEWISVA

Related Medical Topics

This summary article refers to the following medical categories:

  • Medication
  • Medication and herceptin
  • Medication and breast cancer
  • Medication and chemotherapy
  • Medication and chemotherapeutic drug
  • Medication and gene therapy
  • Medication and cancer of the breast
  • Research
  • Research and herceptin
  • Research and breast cancer
  • Research and chemotherapy
  • Research and chemotherapeutic drug
  • Research and gene therapy
  • Research and cancer of the breast

More News Topics

  • Restless legs syndrome affects mood
  • Rett Syndrome misdiagnosed as developmental delay
  • Review of trials establishes link between HRT and stroke
  • Rheumatoid arthritis and heart disease link
  • Rheumatoid arthritis influenced by genetics and tobacco
  • Rheumatoid arthritis sufferers face greater risk of silent heart disease
  • Rhinosinusitis diagnosis needs clearer diagnosis guidelines and more research
  • Risk factors for postnatal depression defined
  • Risk of bleeding increases when COX-2 inhibitor use is combined with warfarin
  • Risk of IVF inducing birth defects small
  • Risk of sinus infection increases with Autumn
  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise